Journal
MICROBIOLOGY SPECTRUM
Volume 1, Issue 2, Pages -Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/microbiolspec.AID-0002-2012
Keywords
-
Categories
Funding
- NIH [U54-AI057158]
- Pfizer's Centers for Therapeutic Innovation, New York
Ask authors/readers for more resources
Staphylococcal enterotoxin B is one of the most potent bacterial superantigens that exerts profound toxic effects upon the immune system, leading to stimulation of cytokine release and inflammation. It is associated with food poisoning, nonmenstrual toxic shock, atopic dermatitis, asthma, and nasal polyps in humans. Currently, there is no treatment or vaccine available. Passive immunotherapy using monoclonal antibodies made in several different species has shown significant inhibition in in vitro studies and reduction in staphylococcal enterotoxin B-induced lethal shock in in vivo studies. This should encourage future endeavors to develop these antibodies as therapeutic reagents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available